Structure of prolyl-tRNA synthetase-halofuginone complex provides basis for development of drugs against malaria and toxoplasmosis
The Chinese herb Dichroa febrifuga has traditionally treated malaria-associated fever. Its active component febrifugine (FF) and derivatives such as halofuginone (HF) are potent anti-malarials. Here, we show that FF-based derivatives arrest parasite growth by direct interaction with and inhibition o...
Egile Nagusiak: | Jain, V, Yogavel, M, Oshima, Y, Kikuchi, H, Touquet, B, Hakimi, M, Sharma, A |
---|---|
Formatua: | Journal article |
Argitaratua: |
Cell Press
2015
|
Antzeko izenburuak
-
Targeting prolyl-tRNA synthetase to accelerate drug discovery against malaria, leishmaniasis, toxoplasmosis, cryptosporidiosis, and coccidiosis.
nork: Jain, V, et al.
Argitaratua: (2017) -
Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistance
nork: Mark A. Tye, et al.
Argitaratua: (2022-08-01) -
Targeting prolyl-tRNA synthetase via a series of ATP-mimetics to accelerate drug discovery against toxoplasmosis
nork: Manickam Yogavel, et al.
Argitaratua: (2023-02-01) -
Targeting prolyl-tRNA synthetase via a series of ATP-mimetics to accelerate drug discovery against toxoplasmosis.
nork: Manickam Yogavel, et al.
Argitaratua: (2023-02-01) -
Double drugging of prolyl-tRNA synthetase provides a new paradigm for anti-infective drug development.
nork: Yogavel Manickam, et al.
Argitaratua: (2022-03-01)